Population-based HIV Impact Assessments in | CDC RFA GH14 140904CONT17

Opportunity Information: Apply for CDC RFA GH14 140904CONT17

This funding opportunity, titled "Population-based HIV Impact Assessments in Resource-Constrained Settings" (Funding Opportunity Number: CDC RFA GH14-140904CONT17), is a continuation cooperative agreement offered by the U.S. Department of Health and Human Services through the Centers for Disease Control and Prevention (CDC), specifically within CDC's global health programs (CGH). It sits within the health funding activity category and is associated with CFDA number 93.067, which generally covers CDC global HIV/AIDS-related public health efforts. The opportunity was created on February 9, 2017, with an original closing date of March 29, 2017, and it anticipated making about 10 awards.

The purpose of the opportunity is to support Population-based HIV Impact Assessments (PHIAs) in resource-constrained settings under the umbrella of the U.S. President's Emergency Plan for AIDS Relief (PEPFAR). In practical terms, PHIAs are large, nationally (or regionally) representative household surveys designed to measure the real-world impact of HIV programs by producing high-quality estimates of HIV burden and key prevention and treatment indicators across the general population. These assessments typically aim to provide data on HIV prevalence, incidence (in some cases, depending on the design and laboratory methods), knowledge of HIV status, antiretroviral therapy (ART) coverage, and viral load suppression, often aligned with global targets such as the "90-90-90" framework that was prominent during that period. Because they are population-based, PHIAs help fill gaps left by routine clinic data by capturing people who may not be engaged in care and by providing denominators needed to interpret program reach and impact.

As a continuation award, the opportunity indicates ongoing support for work that was already underway rather than a brand-new standalone competition. Cooperative agreement as the funding instrument type is also meaningful: it generally implies substantial involvement by the CDC in the supported activities. That can include technical assistance in survey design, sampling approaches, laboratory systems, data management and analysis, quality assurance, and dissemination of findings, rather than the recipient operating entirely independently as would often be the case under a standard grant. The continuation structure and cooperative agreement model fit the reality that PHIAs are complex, multi-partner efforts that require consistent methods, strong quality control, and coordination with national ministries of health, implementing partners, and laboratories.

Eligibility is listed broadly as "Others" with additional clarification referenced in the original announcement's eligibility text. In federal grant language, that typically means eligibility may include a specific set of organizations beyond the common categories, potentially such as ministries of health, international organizations, universities, non-governmental organizations, and other entities with demonstrated capacity to conduct large-scale population surveys, manage field operations, ensure ethical compliance and human subjects protections, and implement HIV-related laboratory testing and data systems. Because the eligibility note points to additional text, the definitive list would be in the full funding announcement.

The award ceiling is shown as 0 in the summary data provided, which usually means the ceiling was not specified in that particular listing or was described elsewhere in the full announcement or continuation documentation. The expected number of awards (10) gives a sense of scale: CDC anticipated supporting multiple country or site assessments rather than a single project, consistent with PEPFAR's multi-country footprint.

Overall, the opportunity supports the generation of rigorous, population-level evidence about HIV epidemic status and program performance in settings where routine surveillance and health information systems may have limitations. The results from PHIAs are typically used to guide national and donor decision-making, identify geographic or demographic gaps in testing and treatment, estimate progress toward HIV control benchmarks, and prioritize resources to where they will have the most impact.

• The Department of Health and Human Services, Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Population-based HIV Impact Assessments in" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
• This funding opportunity was created on Feb 09, 2017.
• Applicants must submit their applications by Mar 29, 2017. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 10 candidate(s).
• Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).

Apply for CDC RFA GH14 140904CONT17

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: